Stroke
Pooled data from 5 randomized controlled trials reveals that endovascular therapy plus standard care is more cost-effective from a US healthcare perspective than standard care alone for the management of acute ischemic large vessel occlusion (LVO). The evidence, published online October 6, 2016, in Stroke
Interventionalists should be free to choose their preferred mechanical thrombectomy device, whether Solitare or Trevo, when treating patients with acute ischemic stroke, according to a fresh analysis of data from the MR CLEAN trial.…
There is a potential role for endovascular intervention among patients with large vessel occlusions (LVOs) who present with minimal symptoms, according to research published online September 2, 2016, ahead of print in the Journal of NeuroInterventional Surgery.…
Clot length does not appear to be a relevant clinical factor when selecting patients for thrombectomy for the treatment of acute ischemic stroke. Results of a small retrospective study published online September 15, 2016, ahead of print in the Journal of NeuroInterventional Surgery suggest there is no link between clot length and the risk of complications or poor outcome.…
Combining use of both a stent retriever and an intracranial aspiration catheter to achieve revascularization after large vessel occlusion can speed the time to recanalization and reduce the number of passes needed, according to a retrospective analysis published online September 1, 2016, ahead of print in the Journal of NeuroInterventional Surgery.…
Page 32 of 43